John E. Harris, Amit G. Pandya, Mark Lebwohl, Iltefat H. Hamzavi, Pearl Grimes, Alice B. Gottlieb, . . . David Rosmarin. (2024). Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years. Wiley.
Chicago Style (17th ed.) CitationJohn E. Harris, et al. Safety and Efficacy of Ruxolitinib Cream for the Treatment of Vitiligo: A Randomised Controlled Trial Secondary Analysis at 3 years. Wiley, 2024.
MLA (9th ed.) CitationJohn E. Harris, et al. Safety and Efficacy of Ruxolitinib Cream for the Treatment of Vitiligo: A Randomised Controlled Trial Secondary Analysis at 3 years. Wiley, 2024.
Warning: These citations may not always be 100% accurate.